Become a partner

Our partner program is designed for healthcare providers, diagnostic laboratories, longevity clinics, telehealth providers, and distributors with experience in medical testing or preventive health services. We also collaborate with established diagnostic networks seeking to expand into advanced longevity testing.

We support several partnership models depending on scale and capabilities, including: • Clinical provider partnerships • Diagnostic laboratory partnerships • Regional distribution agreements • Strategic licensing or joint venture structures for high-volume markets • Individual agent agreement

In some markets, regional exclusivity may be considered for partners who demonstrate: • Established healthcare networks • Regulatory readiness • Strong commercial infrastructure • Clear volume projections and minimum annual volume commitments

Distributors are responsible for commercial activities in their region, including: • Market development and sales • Engagement with healthcare providers and clinics • Distribution of sample collection kits • Coordination of sample logistics • Customer support and training for local providers Laboratory analysis and report generation are performed by the certified laboratories connected to the BioAgeDiagnostics platform.

Volume expectations vary by partnership model. Clinical providers typically start without minimums, while regional distribution or laboratory licensing arrangements may require agreed annual volumes.

Yes. Commercial partners receive access to: • Product training and educational materials • Scientific documentation and validation studies • Patient-facing educational content • Marketing support resources This ensures distributors can communicate the clinical value of the tests effectively.

We work with partners globally across Europe, the Middle East, Asia-Pacific, and the Americas. Regional availability may depend on regulatory considerations and logistics.

Our platform provides access to advanced diagnostics including: • Epigenetic biological age testing • DNA-based health risk analysis • Microbiome analysis • NAD+ test Tests are sourced from clinically validated laboratories specializing in precision and longevity medicine.

All tests available through the platform are developed by certified laboratories and are supported by peer-reviewed scientific research and validated analytical methods.

Laboratory analysis is conducted by certified reference laboratories that comply with international quality standards such as CLIA, CAP, or ISO 15189 where applicable.

Laboratory partners must be able to handle biological samples under validated temperature conditions and follow standardized collection and storage protocols. Typical requirements include: • Controlled temperature storage (2–8°C or frozen storage where required) • Standardized sample preparation • Compliance with international biological sample transport regulations • Detailed logistics and handling procedures are provided during partner onboarding.

Laboratory partners typically upload raw data or analytical outputs to a secure analysis platform where advanced bioinformatic processing and report generation occur. This ensures consistent interpretation of results while allowing laboratory partners to perform local analytical workflows.

Laboratory partners are responsible for ensuring compliance with local regulatory requirements governing diagnostic testing and sample handling in their jurisdiction. The partnership framework will take into account: • National laboratory regulations • Data privacy and health information laws • Import/export regulations for biological samples when applicable

Licensed healthcare professionals including physicians, functional medicine practitioners, longevity specialists, and other qualified clinicians may order tests through the platform. Many tests are designed to support preventive medicine, metabolic health monitoring, and longevity-focused care.

Sample collection methods depend on the specific test and may include: • Blood samples • Saliva samples • Buccal swabs • Stool samples Detailed instructions and collection kits are provided to partner clinics.

Test results are delivered through Clinician Portals on each of the lab tests. Reports are designed to support clinical interpretation and may include: • Biomarker results • Clinical context and interpretation guidance • Tailored protokols

Yes. Commercial partners receive access to: • Product training and educational materials • Scientific documentation and validation studies • Patient-facing educational content • Marketing support resources This ensures distributors can communicate the clinical value of the tests effectively.

We work with partners globally across Europe, the Middle East, Asia-Pacific, and the Americas. Regional availability may depend on regulatory considerations and logistics.

Depending on the section you are viewing: The Ageing Entropy curve for each function and the biological ages for various body systems are derived from a healthy reference population across different age groups. While both healthy and unhealthy populations are used during product development and validation, the data used for the Ageing Entropy curve and bio-noise calculations come from healthy individuals of various ages. For calculations such as age difference, ageing speed, and ageing factors, we compare your biological age results with your chronological age or compare the biological age across your different body systems. This helps identify which systems may need the most attention, specifically for you as Top Ageing factors.

Our platform provides access to advanced diagnostics including: • Epigenetic biological age testing • DNA-based health risk analysis • Microbiome analysis • NAD+ test Tests are sourced from clinically validated laboratories specializing in precision and longevity medicine.

All tests available through the platform are developed by certified laboratories and are supported by peer-reviewed scientific research and validated analytical methods.

Quality assurance is essential for maintaining test reliability. Laboratory partners must follow validated protocols, standardized reagents, and predefined quality control procedures. Quality oversight may include: • Laboratory validation processes • Periodic proficiency testing • Standardized operating procedures • External quality audits when applicable • Bioinformatic processing and algorithmic interpretation are typically managed centrally to ensure consistency across regions.

Laboratory partners must be able to handle biological samples under validated temperature conditions and follow standardized collection and storage protocols. Typical requirements include: • Controlled temperature storage (2–8°C or frozen storage where required) • Standardized sample preparation • Compliance with international biological sample transport regulations • Detailed logistics and handling procedures are provided during partner onboarding.

Laboratory partners typically upload raw data or analytical outputs to a secure analysis platform where advanced bioinformatic processing and report generation occur. This ensures consistent interpretation of results while allowing laboratory partners to perform local analytical workflows.

Laboratory partners are responsible for ensuring compliance with local regulatory requirements governing diagnostic testing and sample handling in their jurisdiction. The partnership framework will take into account: • National laboratory regulations • Data privacy and health information laws • Import/export regulations for biological samples when applicable

Volume expectations depend on the partnership model. Laboratories participating in sample collection or logistics typically have flexible volume requirements. Local laboratory execution or licensing models are generally considered for partners with sufficient projected test volumes to support operational validation and quality oversight.

Accredited diagnostic laboratories with capabilities in molecular diagnostics, genomics, or advanced biomarker analysis may apply to become a laboratory partner. Ideal partners typically operate under recognized quality standards such as CLIA, CAP, ISO 15189, or equivalent national laboratory accreditation. Laboratories should have experience with high-throughput testing, standardized quality control procedures, and secure handling of sensitive biological data.

Depending on the partner’s infrastructure and projected testing volumes, several collaboration models may be considered: • Sample collection and logistics partner – Local laboratories collect and prepare samples for shipment to a central reference laboratory. • Wet-lab partner – The laboratory performs parts of the analytical workflow such as DNA extraction or sample preparation. • Regional processing laboratory – High-volume partners may perform the wet-lab component locally while bioinformatic analysis and algorithmic interpretation are performed centrally. • Licensed regional laboratory – For large-scale operations, a licensing model may allow local sequencing or analysis with centralized algorithm access. The appropriate structure depends on laboratory capabilities, regulatory requirements, and projected test volumes.

Laboratories interested in performing analytical components locally should typically have capabilities such as: • DNA extraction and sample preparation • Next-generation sequencing or equivalent genomic analysis • Quality-controlled molecular workflows • Standardized laboratory information management systems (LIMS) • Temperature-controlled sample storage and logistics • Specific technical requirements depend on the test panel and will be provided during the technical evaluation process.

Quality assurance is essential for maintaining test reliability. Laboratory partners must follow validated protocols, standardized reagents, and predefined quality control procedures. Quality oversight may include: • Laboratory validation processes • Periodic proficiency testing • Standardized operating procedures • External quality audits when applicable • Bioinformatic processing and algorithmic interpretation are typically managed centrally to ensure consistency across regions.

In most cases, laboratory partnerships are implemented in phases. Initial collaboration often begins with sample collection or partial processing while testing demand is established. For partners with sufficient infrastructure and test volumes, localized laboratory execution may be considered following technical validation and regulatory review.

Laboratory partners must be able to handle biological samples under validated temperature conditions and follow standardized collection and storage protocols. Typical requirements include: • Controlled temperature storage (2–8°C or frozen storage where required) • Standardized sample preparation • Compliance with international biological sample transport regulations • Detailed logistics and handling procedures are provided during partner onboarding.

Laboratory partners typically upload raw data or analytical outputs to a secure analysis platform where advanced bioinformatic processing and report generation occur. This ensures consistent interpretation of results while allowing laboratory partners to perform local analytical workflows.

Laboratory partners are responsible for ensuring compliance with local regulatory requirements governing diagnostic testing and sample handling in their jurisdiction. The partnership framework will take into account: • National laboratory regulations • Data privacy and health information laws • Import/export regulations for biological samples when applicable

Volume expectations depend on the partnership model. Laboratories participating in sample collection or logistics typically have flexible volume requirements. Local laboratory execution or licensing models are generally considered for partners with sufficient projected test volumes to support operational validation and quality oversight.

Interested laboratories can submit a partnership inquiry through the partner portal. The onboarding process typically includes: • Initial laboratory capability review • Technical discussion with the scientific team • Assessment of regulatory and logistics requirements • Definition of the appropriate partnership structure